Article
Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps.
Diabetologia - 1 Sept 2008
Groenewoud M J, Dekker J M, Fritsche A, Reiling E, Nijpels G, Heine R J, Maassen J A, Machicao F, Schäfer S A, Häring H U, 't Hart L M, van Haeften T W
Abstract excerpt
AIMS/HYPOTHESIS: Genome-wide association studies have recently identified novel type 2 diabetes susceptibility gene regions. We assessed the effects of six of these regions on insulin secretion as determined by a hyperglycaemic clamp. METHODS: Variants of the HHEX/IDE, CDKAL1, SLC30A8, IGF2BP2 and CDKN2A/CDKN2B genes were genotyped in a cohort of 146 participants with NGT and 126 with IGT from the Netherlands and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
